Understand the immune system’s role in celiac disease and how it affects people diagnosed with the condition.
Educational Abstract: Differentiating Celiac Disease and Non-Celiac Gluten Sensitivity, The Immune Pathways Involved, and How Integrative Chiropractic and Functional Medicine Care Fit Into a Comprehensive, Evidence-Based Plan
In this educational post, I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, guide you through a clear, step-by-step understanding of gluten-related disorders—specifically the crucial distinctions between celiac disease and non-celiac gluten sensitivity (NCGS). I explain the immune mechanisms behind each condition, the key roles of gliadin, zonulin, tight junctions, tissue transglutaminase (tTG), and immunoglobulins (IgA/IgG), and why this physiology can lead to systemic manifestations that reach far beyond the gut.
I also introduce our collaborative, multidisciplinary model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas—where I integrate chiropractic care, functional medicine, rehabilitation, and personal injury services under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). With over 40 years of experience as an internist, Dr. Cardenas serves as our Medical Director and Collaborative Physician, ensuring evidence-based diagnostic rigor, safety, and continuity of care while I lead the conservative, biomechanical, and lifestyle-driven components.
You will see how integrative chiropractic care fits into this clinical picture—optimizing neuromusculoskeletal function, modulating autonomic tone, supporting lymphatic and venous return, and enhancing rehabilitation outcomes. At the same time, we address nutrition, gut-immune integrity, and systemic inflammation. We will walk through the science, practical testing protocols (including the need for gluten exposure before celiac serology), and how to build individualized plans that are safe, staged, and sustainable.
By the end, you will understand why celiac disease is a lifelong autoimmune enteropathy requiring strict gluten elimination, why NCGS is an innate immune phenomenon that can be reversible, and how a coordinated, evidence-based care team can help you recover gut barrier function, reduce skin, neurological, and cardiovascular risks, and return to function with clear goals and measurable outcomes.
Who I Am and How We Work As A Team
I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In our El Paso practice, Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), I collaborate closely with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). Dr. Cardenas is our Medical Director and Collaborative Physician. Together, we provide a multidisciplinary standard of care that blends:
- Medical oversight, diagnostics, and risk management under Internal Medicine
- Integrative chiropractic care for spine, joint, and neuromuscular optimization
- Functional medicine for gut-immune axis, nutrition, and lifestyle therapeutics
- Rehabilitation, corrective exercise, and postural-neuromuscular retraining
- Personal injury care with evidence-based outcome tracking
- Coordination with outside specialists when indicated
Our clinical approach is pragmatic: we use modern, evidence-based research applied through conservative, patient-centered care pathways. The integrative model is especially important for complex, multi-system issues like gluten-related disorders, where gut mucosa, immune tone, neurological input/output, autonomic regulation, and biomechanical stressors interplay.
References to my clinical observations and ongoing discussions within our community can be explored at PushAsRx and my LinkedIn page:
Celiac Disease vs. Non-Celiac Gluten Sensitivity: Why The Distinction Matters
I frequently encounter confusion about the difference between celiac disease and non-celiac gluten sensitivity (NCGS). Although many people lump them together, they are pathophysiologically distinct:
- Celiac disease is a chronic, autoimmune enteropathy triggered by gluten in genetically susceptible individuals. It involves an adaptive immune response with specific antibodies against tissue transglutaminase (tTG) and deamidated gliadin peptides (DGP), and it can produce villous atrophy and malabsorption. It is permanent and requires lifelong strict gluten elimination (Lebwohl et al., 2018; Rubio-Tapia et al., 2013).
- NCGS is a non-autoimmune, non-allergic reaction to gluten or other wheat components (such as amylase-trypsin inhibitors or fructans) that appears to involve the innate immune system and epithelial barrier dysfunction, but does not produce the characteristic celiac autoantibodies or villous atrophy (Volta et al., 2014; Skodje et al., 2018; Uhde et al., 2016).
Key takeaways:
- Celiac disease is an adaptive immune disorder with self-directed antibodies and intestinal architecture damage.
- NCGS is more of an innate immune activation and epithelial barrier irritation without the autoimmune features seen in celiac disease.
- The clinical overlap can be significant—bloating, pain, diarrhea, brain fog, fatigue—but the long-term risks, testing strategies, and treatment implications differ substantially.
In our clinic, this distinction guides everything from lab selection and imaging to nutrition plans, neuromuscular rehab pacing, and long-term follow-up.
Citations:
- Lebwohl, B., Sanders, D. S., & Green, P. H. R. (2018). Coeliac disease. The Lancet. https://doi.org/10.1016/S0140-6736(18)31796-8
- Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H., & Murray, J. A. (2013). ACG clinical guidelines: Diagnosis and management of celiac disease. American Journal of Gastroenterology. https://doi.org/10.1038/ajg.2013.79
- Volta, U., Bardella, M. T., Calabrò, A., Troncone, R., & Corazza, G. R. (2014). An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Medicine. https://doi.org/10.1186/1741-7015-12-85
- Skodje, G. I., et al. (2018). Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology. https://doi.org/10.1053/j.gastro.2017.10.040
- Uhde, M., et al. (2016). Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease. Gut. https://doi.org/10.1136/gutjnl-2016-311964
The Immunology of Celiac Disease: From Gliadin to Autoantibodies
When someone with celiac disease consumes gluten, specific protein fractions—particularly gliadin—are deamidated by the enzyme tissue transglutaminase (tTG) in the lamina propria. This deamidation enhances the binding affinity of gliadin peptides to HLA-DQ2 or HLA-DQ8 molecules on antigen-presenting cells, which then activate gluten-specific CD4+ T cells. The cascade leads to:
- Production of proinflammatory cytokines (e.g., IFN-γ, IL-21)
- B-cell activation and production of anti-tTG IgA and IgG, and anti-deamidated gliadin peptide (DGP) antibodies
- Intraepithelial lymphocytosis and cytotoxicity against enterocytes
- Villous atrophy and crypt hyperplasia, reducing absorptive surface area (Fasano et al., 2012; Sollid & Jabri, 2013)
Physiological impact:
- Malabsorption of iron, calcium, folate, vitamin D, B12, and fat-soluble vitamins
- Secondary effects including osteoporosis/osteopenia, anemia, peripheral neuropathy, infertility, dermatitis herpetiformis, and potential cardiovascular risks linked to chronic inflammation (Kaukinen et al., 2010; Ludvigsson et al., 2013).
This is the classic adaptive immune pattern—self-directed immune activity driven by antigen presentation and specific autoantibody formation.
Citations:
- Fasano, A., et al. (2012). Celiac disease: Pathogenesis, epidemiology, clinical manifestations, diagnosis, and management. Gastroenterology. https://doi.org/10.1053/j.gastro.2012.02.010
- Sollid, L. M., & Jabri, B. (2013). Triggers and drivers of autoimmunity: Lessons from coeliac disease. Nature Reviews Immunology. https://doi.org/10.1038/nri3537
- Kaukinen, K., et al. (2010). Celiac disease and autoimmunity. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2009.10.009
- Ludvigsson, J. F., et al. (2013). Risks of autoimmune, psychiatric and neurological diseases in patients with biopsy-verified celiac disease: A population-based study. Journal of Internal Medicine. https://doi.org/10.1111/joim.12062
Zonulin, Tight Junctions, and Intestinal Permeability
The intestinal barrier is one cell thick, sealed by tight junction proteins such as claudins, occludin, and junctional adhesion molecules. Gliadin can trigger zonulin release—a tight junction modulator—leading to increased intestinal permeability in susceptible individuals. Enhanced permeability allows luminal antigens (bacterial fragments like LPS, dietary proteins, toxins) to translocate into the lamina propria and systemic circulation, priming immune activation (Fasano, 2012; Sturgeon & Fasano, 2016).
Key concepts:
- Tight junctions act as gates controlling paracellular traffic. When zonulin is upregulated, those gates loosen.
- Increased permeability is not unique to celiac disease; it can occur in NCGS, IBS, metabolic syndrome, and other inflammatory states.
- Long-term permeability changes amplify antigenic load and contribute to systemic symptoms: fatigue, brain fog, skin eruptions, arthralgia, mood changes.
Citations:
The Role of Tissue Transglutaminase and Autoimmunity
Tissue transglutaminase (tTG) deamidates gliadin peptides, making them more immunogenic for presentation by HLA-DQ2/DQ8. In celiac disease, the immune system generates antibodies against tTG. These anti-tTG antibodies are highly specific for celiac disease and form the basis of the standard serologic tests (tTG-IgA, with total serum IgA to rule out IgA deficiency). Dermatitis herpetiformis occurs when IgA-tTG (or IgA-epidermal transglutaminase) immune complexes deposit in dermal papillae, triggering complement activation, neutrophil recruitment, and the pathognomonic itchy vesicles (Zone et al., 2015; Salmi et al., 2014).
Clinical implications:
- Anti-tTG IgA is the first-line test for celiac disease screening, provided the patient regularly consumes gluten.
- If IgA deficiency is present, tTG-IgG or DGP-IgG can be used.
- Biopsy via upper endoscopy remains part of the gold standard in many guidelines, especially for adults, though non-biopsy pathways exist in children with high tTG titers (Husby et al., 2020).
Citations:
Why Eating Gluten Before Testing Matters: Avoiding False Negatives
I tell patients clearly: if you suspect celiac disease, do not stop gluten before appropriate testing. The tTG-IgA test and other serologies rely on immune activation driven by gluten exposure. If you have been strictly gluten-free leading up to the test, the antibody levels can normalize, yielding false negatives (ACG Guidelines; Lebwohl et al., 2018).
Practical points we follow under Dr. Cardenas’s medical direction:
- A planned gluten challenge for at least 2–6 weeks, often 3–8 grams of gluten/day, before serology and possible endoscopic biopsy, unless contraindicated due to severe reactions.
- Assess total IgA to identify IgA deficiency; if deficient, use IgG-based tests (tTG-IgG or DGP-IgG).
- If high-risk features exist (e.g., significant weight loss, anemia, severe dermatitis herpetiformis), coordinate expedited specialist input.
Citations:
Non-Celiac Gluten Sensitivity: Innate Immunity and Trigger Diversity
In NCGS, the immune response appears to be driven predominantly by innate pathways rather than the adaptive, autoantibody-mediated responses of celiac disease. Studies suggest several potential triggers in wheat beyond gluten, including amylase-trypsin inhibitors (ATIs) that activate toll-like receptor 4 (TLR4) and fructans (a FODMAP) that ferment and create symptoms in sensitive individuals (Junker et al., 2012; Skodje et al., 2018).
Mechanisms implicated:
- Innate immune activation via pattern recognition receptors (e.g., TLRs), leading to cytokine release and barrier irritation.
- Low-grade mucosal inflammation without villous atrophy.
- Increased intestinal permeability in some patients, possibly transient and reversible with dietary modification and microbiome support (Uhde et al., 2016).
Clinically, symptoms overlap with IBS—gas, bloating, abdominal pain, altered bowel habits, brain fog, fatigue. The absence of celiac autoantibodies and normal duodenal histology help distinguish NCGS from celiac disease.
Citations:
Threshold Dynamics: The Bucket Analogy and Why Symptoms Often Start Later In Life
Patients often ask why symptoms appear in their thirties or forties if they have eaten wheat their entire lives. I use a simple analogy: your gut-immune system is a bucket. Over time, stressors accumulate—medications (e.g., NSAIDs), infections, dysbiosis, chronic stress, micronutrient deficiencies, environmental toxins, sleep debt, and dietary irritants. Eventually, the bucket reaches capacity, leading to increased epithelial permeability and exaggerated immune signaling.
Physiology under this model:
- Chronic psychosocial stress elevates cortisol and catecholamines, modulating mucosal immunity and tight junction proteins via glucocorticoid and adrenergic signaling pathways.
- NSAIDs and alcohol can perturb tight junctions and mitochondrial function in enterocytes, promoting permeability.
- Dysbiosis alters short-chain fatty acid (SCFA) profiles, bile acid metabolism, and mucin regulation, weakening barrier integrity.
- When gliadin or wheat components pass through a compromised barrier, they meet an immune system already primed to react.
This explains why onset can be delayed: it is not a single trigger but a cumulative load that tips the system.
Citations:
Eating Right to Feel Better-Video
Systemic Effects: How Gut Immune Activation Reaches the Skin, Nerves, Bones, and Heart
When intestinal permeability increases and immune activation escalates, effects radiate throughout the body:
- Skin: Dermatitis herpetiformis in celiac disease involves IgA deposits at the dermal papillae. More broadly, systemic cytokines, mast cell activation, and histamine release can drive itching, flushing, and dysesthesia.
- Neurology: Peripheral neuropathy, ataxia, migraines, and cognitive symptoms can occur in celiac disease and sometimes in NCGS; mechanisms include nutrient deficiency, autoimmunity, and neuroinflammation (Hadjivassiliou et al., 2010).
- Bone: Villous atrophy leads to calcium and vitamin D malabsorption, secondary hyperparathyroidism, and bone resorption, increasing osteoporosis risk (Valdimarsson et al., 1996).
- Cardiometabolic: Chronic inflammation, homocysteine elevation due to folate/B12 deficiency, and endothelial dysfunction can contribute to cardiovascular Risk in untreated celiac disease (Emilsson et al., 2011).
In our integrative model, we screen for these risks and design interventions that address the root causes—restoring barrier function, normalizing nutrient status, and recalibrating inflammatory signaling.
Citations:
Diagnostic Pathways: How We Evaluate Suspected Gluten-Related Disorders
Under Dr. Cardenas’s medical leadership, we follow a structured pathway:
- History and risk assessment
-
- Family history of celiac disease, autoimmune conditions
- Symptom inventory: GI (diarrhea, constipation, pain, bloating), dermatologic (pruritus, vesicles), neurologic (paresthesia, ataxia), fatigue, mood, menstrual and reproductive history
- Diet history, supplement use, medications (NSAIDs, PPIs), alcohol, travel/infections
-
- Signs of nutrient deficiency (pallor, glossitis, cheilitis), dermatitis herpetiformis, neurologic signs, musculoskeletal tenderness, postural compensations
-
- Serology while on gluten: tTG-IgA with total IgA; if IgA deficient, tTG-IgG or DGP-IgG; consider EMA-IgA confirmation
- Nutrient screens: CBC, ferritin, iron studies, folate, B12, 25(OH)D, calcium, magnesium, zinc
- Inflammation markers: hs-CRP; consider fecal calprotectin if IBD is in the differential
- Thyroid panel if autoimmune clustering suspected
-
- Upper endoscopy with duodenal biopsies for definitive diagnosis in adults with positive serology or high clinical suspicion
- DEXA scan if osteoporosis risk present
-
- Rule out IBD, microscopic colitis, SIBO, pancreatic insufficiency, lactose intolerance, bile acid diarrhea, IBS.
- For suspected NCGS after celiac exclusion
-
- A structured elimination-rechallenge protocol, often with blinded or double-blinded food challenges when feasible
- Consider low-FODMAP trial to test fructan sensitivity
Citations:
Why Integrative Chiropractic Care Belongs In This Conversation
Many patients ask how chiropractic fits into a conversation about gut and immune health. The short answer: your neuromusculoskeletal system, autonomic nervous system, lymphatic circulation, and mechanics of breathing and posture all influence the gut-immune axis. My role is to optimize these systems to reduce allostatic load, improve function, and create a physiological environment in which the gastrointestinal tract can heal.
Mechanisms through which integrative chiropractic care supports recovery:
- Autonomic modulation: Targeted manual therapies, spinal manipulative therapy, and soft tissue work can influence sympathetic-parasympathetic balance. Improved vagal tone supports motility, mucosal immunity, and anti-inflammatory signaling via the cholinergic anti-inflammatory pathway.
- Pain reduction and central sensitization: By reducing nociceptive input through mobilization, manipulation, and corrective exercise, we can dampen central sensitization that otherwise perpetuates visceral hypersensitivity and gut symptom perception.
- Breathing mechanics and diaphragmatic function: The diaphragm is both a respiratory and postural muscle. Optimizing diaphragmatic excursion improves lymphatic and venous return, supports gut motility, and reduces intra-abdominal pressure dysregulation.
- Posture and thoracolumbar mechanics: Mobility at the thoracolumbar junction influences rib mechanics and abdominal wall tension; restoring mobility can reduce pressure on visceral structures and improve exercise tolerance.
- Lymphatic and venous return: Gentle oscillatory techniques, rib cage mobility work, and targeted movement strategies enhance fluid dynamics that clear inflammatory mediators.
In our clinic, we never use these strategies in isolation. We sequence them with medical evaluation, nutrition, and rehabilitative care under Dr. Cardenas’s oversight to ensure safety and efficacy.
Citations:
Functional Medicine Integration: Rebuilding the Gut Barrier and Immune Tolerance
Functional medicine principles help us map antecedents, triggers, and mediators. When dealing with gluten-related disorders, my approach includes:
-
- For celiac disease: strict, lifelong elimination of gluten from wheat, barley, rye, and cross-contaminated products.
- For NCGS: tailored elimination of suspected triggers such as gluten, ATIs, and/or fructans, followed by systematic reintroduction to confirm sensitivity.
- Address other irritants: excessive NSAIDs, alcohol, ultra-processed foods, and high-emulsifier foods.
-
- Digestive support where indicated: pancreatic enzymes or bile acid support in insufficiency; betaine HCl only with clear hypochlorhydria and medical clearance.
- Nutrient repletion guided by labs: iron, folate, B12, vitamin D, calcium, magnesium, zinc, omega-3s.
-
- Support a diverse microbiome with prebiotic fibers as tolerated; if you’re sensitive to fructans, start low and titrate.
- Consider strain-specific probiotics for barrier support and immune modulation; evidence varies by strain and indication.
-
- Nutrients that support tight junctions and mucosal integrity: L-glutamine, zinc carnosine, vitamin A, butyrate (from fiber or direct supplementation), polyphenols (e.g., green tea catechins), and omega-3 fatty acids.
- Emphasize whole foods, polyphenol-rich plants, and adequate protein.
-
- Optimize stress physiology: sleep regularity, circadian alignment, breathwork, and HRV-based recovery.
- Movement prescriptions: graded activity, core stability, and gait/posture retraining to reduce mechanical stress and improve autonomic balance.
This framework is customized to the individual and always coordinated with medical evaluation for safety.
Citations:
- De Punder, K., & Pruimboom, L. (2013). The dietary intake of wheat and other cereal grains and their role in inflammation. Nutrients. https://doi.org/10.3390/nu5117717
- van der Meij, B. S., et al. (2013). Micronutrient deficiencies in celiac disease. Nutrients. https://doi.org/10.3390/nu5124416
- Suzuki, T., & Hara, H. (2011). Role of zinc in maintaining intestinal mucosal barrier function and mucosal immune responses. Journal of Nutritional Biochemistry. https://doi.org/10.1016/j.jnutbio.2011.05.001
- Camilleri, M. (2019). Leaky gut: Mechanisms, measurement and clinical implications. Gut. https://doi.org/10.1136/gutjnl-2019-318427
Personal Injury, Rehabilitation, and The Gut-Immune-Movement Triangle
In personal injury and chronic pain contexts, I often see a bidirectional relationship:
- Pain and immobilization elevate sympathetic tone, disturb sleep, and shift gut motility and permeability.
- Gut-driven inflammation heightens central sensitization and pain perception, slowing rehabilitation progress.
Our rehabilitation integrates:
- Graded exposure and progressive loading: tissue remodeling is mechanotransduction-dependent; we dose loading to the current capacity to drive adaptation without flaring systemic inflammation.
- Neuromuscular control and balance: proprioceptive training recalibrates reflex arcs and reduces aberrant co-contraction that feeds pain.
- Breathing retraining: diaphragmatic work lowers accessory muscle overuse, improves HRV, and supports lymph flow.
- Anti-inflammatory lifestyle stacking: aligned nutrition, movement, sleep, and stress strategies to reduce allostatic load.
Citations:
Dairy, Cross-Reactivity, and Molecular Mimicry: What We Tell Patients
Some patients with celiac disease experience symptoms with dairy. Reasons include:
- Secondary lactase deficiency due to villous atrophy
- Potential immune cross-reactivity and altered oral tolerance during active inflammation
- Casein sensitivity in a subset of individuals
Clinical approach:
- In active celiac disease, temporary dairy reduction may improve symptoms until mucosal healing restores lactase activity.
- We reintroduce later, as tolerated, with objective monitoring.
- For NCGS, we use an individualized approach—eliminate and re-challenge to confirm.
Citations:
The Dermatologic Connection: Itch, Blister, and Immune Traffic
When IgA-gluten complexes deposit in the skin’s dermal papillae, complement activation and neutrophil recruitment create the pruritic, blistering rash of dermatitis herpetiformis. Clinically:
- Symmetric involvement of elbows, knees, buttocks, and scalp is common.
- A direct immunofluorescence biopsy of perilesional skin is diagnostic and shows granular IgA deposits.
- Dapsone can rapidly relieve symptoms, but a strict gluten-free diet is essential to address the root cause and reduce tTG-driven autoimmunity (Zone et al., 2015).
Integrative support includes wound-friendly nutrition, adequate zinc and vitamin C, and autonomic-balancing strategies to reduce itch-scratch cycles.
Citations:
Nutrient Malabsorption and Systemic Consequences: Why You Feel Exhausted
Villous atrophy, crypt hyperplasia, and intraepithelial lymphocyte infiltration impair absorptive capacity. Common deficits:
- Iron deficiency anemia: fatigue, dyspnea, decreased exercise tolerance
- Folate and B12: macrocytosis, neuropathy, cognitive changes
- Vitamin D and calcium: osteopenia/osteoporosis, muscle weakness
- Zinc and magnesium: dermatitis, impaired wound healing, cramps
Our protocol includes:
- Baseline labs and periodic rechecks
- Targeted repletion with forms that maximize absorption and minimize GI distress
- Dietary coaching to emphasize bioavailable sources and consistency
Citations:
The Role of Mast Cells, Histamine, and Cytokine Overload
Patients often report itching, flushing, headaches, and food-triggered reactions. Mechanistic threads:
- Zonulin-mediated permeability increases antigen access to submucosal mast cells.
- Mast cell degranulation releases histamine, tryptase, prostaglandins, and cytokines.
- Systemic spillover contributes to brain fog, tachycardia, orthostatic intolerance, and fatigue in susceptible individuals.
Clinical strategies:
- Low-histamine dietary periods as a temporary bridge
- Nutrient support for histamine metabolism (vitamin C, copper-dependent DAO, B6)
- Breathing and vagal tone strategies to blunt sympathetic-driven mast cell activation
- Medical evaluation for MCAS when indicated
Citations:
Building A Safe Gluten Challenge and Testing Plan
When we suspect celiac disease but the patient is already gluten-free, Dr. Cardenas and I design a gluten challenge if medically appropriate:
- Shared decision-making: we discuss risks, benefits, and alternatives.
- Dosing: typically 3–8 grams of gluten/day (about 1–2 slices of wheat bread) for 2–6 weeks, individualized to symptom tolerance.
- Monitoring: symptom diary, rescue strategies, and clear stop criteria for severe reactions.
- Follow-up testing: serology and, if positive or high suspicion persists, endoscopy.
This ensures accurate testing and reduces the Risk of months-long uncertainty or misdiagnosis.
Citations:
How We Sequence Care: From Stabilization To Restoration
Our phased approach aligns medical, chiropractic, and functional medicine steps:
-
- Confirm diagnosis with appropriate testing.
- Reduce symptom generators: elimination diet for celiac or NCGS, hydration, sleep, gentle movement.
- Pain control with conservative modalities; avoid NSAIDs where possible due to gut barrier effects.
- Begin micronutrient repletion.
-
- Integrative chiropractic care to improve autonomic balance, posture, and breath mechanics.
- Targeted gut barrier repair and microbiome support.
- Progressive rehabilitation and activity reintroduction.
-
- Rechallenge non-gluten foods as appropriate to diversify diet.
- Load progression in strength and conditioning, return-to-life goals.
- Ongoing education and self-management strategies.
- Phase 4: Review and Reduce Risk
-
- Monitor labs, DEXA if indicated, dermatology and neurology referrals as needed.
- Update action plans for travel, restaurants, and emergencies.
This roadmap helps patients see the path forward and measure progress.
Citations:
Practical Nutrition: A Real-World, Evidence-Informed Framework
Key nutrition strategies we use:
-
- Strict, lifelong gluten-free diet: eliminate wheat, barley, rye; scrutinize oats for purity and tolerance.
- Label literacy: avoid cross-contamination; separate prep surfaces and utensils.
- Whole-food focus: gluten-free does not mean ultra-processed; emphasize vegetables, fruits, legumes (as tolerated), lean proteins, nuts, seeds, and safe whole grains (rice, quinoa, buckwheat, millet, certified GF oats if tolerated).
- Micronutrient coverage: particularly iron, folate, B12, vitamin D, calcium, zinc.
-
- Start with gluten/wheat elimination; if symptoms persist, evaluate FODMAPs (fructans), ATIs, and emulsifiers. Use a reintroduction protocol to confirm personalized triggers and expand dietary diversity.
-
- Adequate protein for repair and muscle preservation.
- Polyphenol-rich foods for barrier support and anti-inflammatory effects.
- Omega-3s for resolvin pathways.
Citations:
Integrative Chiropractic Techniques: What We Do and Why It Works
Within my scope, I sequence techniques that support physiology:
- Spinal and rib mobilization/manipulation: restores segmental mobility, reduces nociception, and improves respiratory mechanics.
- Myofascial release and instrument-assisted soft tissue: relieves fascial densification, enhances perfusion, and supports lymphatic return.
- Neurodynamic and peripheral joint mobilization: normalizes neural tissue mechanosensitivity and improves movement variability.
- Diaphragmatic training: reinforces lower rib expansion and abdominal pressure regulation to support gut motility and lymph flow.
- Posture and gait rehabilitation: improves load distribution and reduces pain-driven sympathetic arousal.
Results we observe clinically:
- Improved HRV trends
- Reduced pain and GI symptom severity
- Better exercise tolerance and adherence to nutrition plans
Citations:
The Medical DDirector’sRole: Dr. Maria Guadalupe Cardenas, MD
Dr. Cardenas’s experience as a Board-Certified Internist ensures:
- Appropriate diagnostic testing and interpretation for celiac disease and NCGS
- Safety protocols for gluten challenges
- Management of comorbidities: anemia, osteoporosis, thyroid disease, diabetes, cardiovascular Risk
- Indications for imaging, biopsy, DEXA, dermatology, and neurology referrals
- Oversight of medication interactions and contraindications
Her leadership allows our clinic to integrate chiropractic, functional, and rehabilitative modalities with top-tier medical standards.
Personal Injury Interface: Medication Stewardship and Gut Protection
In post-accident care:
- We minimize NSAID exposure when possible due to permeability and microbiome effects.
- If analgesics are necessary, Dr. Cardenas tailors choices to GI risk profiles and monitors for adverse effects.
- We prioritize non-pharmacological pain control, strategic loading, sleep restoration, and nutrition for tissue healing.
Citations:
Sleep, Circadian Health, and Immune Regulation
Sleep disruption elevates inflammatory cytokines and impairs mucosal repair. We coach:
- Consistent sleep and wake times
- Evening light management, morning outdoor light
- Breathwork before bed
- Caffeine timing and alcohol moderation
Citations:
Stress Physiology: Vagal Tone, HRV, and Recovery
We measure and train recovery:
- HRV tracking to gauge autonomic balance
- Slow nasal breathing, extended exhalation, and paced respiration
- Gentle movement snacks throughout the day
- Social connection and sunlight exposure for neuroimmune health
Citations:
Movement as Medicine: Dosing Exercise for Gut and Immune Health
Appropriately dosed exercise:
- Enhances SCFA production via microbiome changes
- Improves insulin sensitivity and endothelial function
- Reduces systemic inflammation via myokines
We tailor:
- Low to moderate aerobic base initially
- Strength training 2–3 days/week
- Mobility and breath-led resets daily
Citations:
Measuring Progress: Biomarkers, Function, and Quality of Life
With Dr. Cardenas’s guidance, we track:
- Serology normalization in celiac disease
- Nutrient status restoration
- DEXA improvements
- Symptom scales (GI distress, pain, fatigue)
- Functional tests: grip strength, gait speed, sit-to-stand
- HRV and sleep metrics
Data give patients confidence and help us iterate care plans.
Safety, Red Flags, and When We Escalate Care
We escalate promptly if any of the following occur:
- Unintentional weight loss, GI bleeding, persistent vomiting
- Severe anemia, refractory symptoms despite strict gluten-free diet
- Night sweats, fevers, or neurological deficits
- Severe or worsening rash, blistering unresponsive to diet
Collaborations may include gastroenterology, dermatology, neurology, endocrinology, or hematology.
What To Expect In Our Clinic: A Patient Journey
- Intake and evaluation: history, physical, initial labs
- Education: understanding celiac vs NCGS and testing sequences
- Stepwise plan: nutrition, chiropractic/rehab, sleep, stress, and movement
- Follow-up cadence: every 2–6 weeks initially; labs rechecked as needed
- Empowerment: skills to read labels, dine out safely, travel, and self-advocate
Common Myths We Dispel
- Myth: A supplement allows you to eat gluten safely in celiac disease.
-
- Reality: No supplement prevents the autoimmune cascade; strict avoidance is required.
- Myth: If you feel better gluten-free, you must have celiac disease.
-
- Reality: NCGS, fructan sensitivity, placebo/nocebo effects, or other dietary changes could explain improvement. Test before eliminating.
-
- Reality: Only certified gluten-free oats; some patients still react.
Citations:
Special Populations: Children, Athletes, and Older Adults
- Children: Growth charts, iron status, and biopsy criteria differ; pediatric gastroenterology input is essential.
- Athletes: High energy expenditure and gut jostling can increase permeability; we manage fueling and timing to reduce GI distress.
- Older adults: Masked presentations (e.g., anemia, osteoporosis) require vigilance; medication reviews are critical.
Citations:
The Economics of Care: Choosing High-Value Steps
We prioritize:
- Evidence-based diagnostics before expensive panels
- Whole-food diet before high-cost supplements
- Behavior change tools that provide compounding returns: sleep, movement, stress skills
Real-World Clinical Observations From Our Practice
At PushAsRx and through my clinical experience, I consistently observe:
- Patients with chronic spine pain and IBS-like symptoms improve when we address breathing mechanics, posture, and diet together.
- HRV-guided training and paced breathing reduce symptom flares and improve adherence to gluten-free diets in celiac disease.
- Early micronutrient repletion accelerates energy recovery, enabling patients to return to rehab more quickly.
Explore more at:
A Coordinated Future: Research Directions and Patient-Centered Innovation
Emerging investigations are exploring:
- Zonulin antagonists to stabilize tight junctions
- ATI-modifying food processing techniques
- Microbiome-directed therapies to build tolerance
- Digital biomarkers (HRV, sleep) that predict flares and guide dosing of rehab and nutrition changes
Our clinic engages with these frontiers while adhering to current best practices and patient safety.
Citations:
Summary and Next Steps
- Celiac disease and NCGS are distinct. Celiac is an adaptive autoimmune response with villous atrophy; NCGS is primarily innate immune irritation without autoimmunity.
- Accurate diagnosis requires gluten exposure before serology and, in adults, often endoscopic confirmation.
- Integrative care—medical oversight, chiropractic optimization, functional medicine nutrition, and targeted rehabilitation—provides a comprehensive path to healing.
- With Dr. Maria Guadalupe Cardenas, MD, as Medical Director, our clinic ensures safety, precision, and a personalized, evidence-based plan.
If you suspect celiac disease or NCGS, do not start a gluten-free diet before appropriate testing. Contact our team for an assessment and a clear plan.
References
- [ACG clinical guidelines: Diagnosis and management of celiac disease] (https://doi.org/10.1038/ajg.2013.79). Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H., & Murray, J. A. (2013). American Journal of Gastroenterology.
- [Breathing pattern disorders and respiratory muscle dysfunction] (https://doi.org/10.1183/20734735.0204-2019). Courtney, R. (2019). Breathe.
- [Celiac disease: Pathogenesis, epidemiology, clinical manifestations, diagnosis, and management] (https://doi.org/10.1053/j.gastro.2012.02.010). Fasano, A., Catassi, C., et al. (2012). Gastroenterology.
- [Clarke, S. F., et al. Exercise and the microbiome] (https://doi.org/10.4161/gmic.28630). Gut Microbes. (2014).
- [Coeliac disease] (https://doi.org/10.1016/S0140-6736(18)31796-8). Lebwohl, B., Sanders, D. S., & Green, P. H. R. (2018). The Lancet.
- [Dermatitis herpetiformis] (https://doi.org/10.1016/j.clindermatol.2014.10.014). Zone, J. J., Taylor, T. B., et al. (2015). Clinics in Dermatology.
- [Exercise as medicine—Evidence for prescribing exercise as therapy in 26 different chronic diseases] (https://doi.org/10.1111/sms.12581). Pedersen, B. K., & Saltin, B. (2015). Scandinavian Journal of Medicine & Science in Sports.
- [Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease] (https://doi.org/10.1136/gutjnl-2016-311964). Uhde, M., Ajamian, M., et al. (2016). Gut.
- [Leaky gut: Mechanisms, measurement and clinical implications in humans] (https://doi.org/10.1136/gutjnl-2019-318427). Camilleri, M. (2019). Gut.
- [Non-celiac gluten sensitivity: The new frontier of gluten-related disorders] (https://doi.org/10.3390/nu7042135). Catassi, C., Elli, L., et al. (2015). Nutrients.
- [Prostaglandins, NSAIDs, and gastric mucosal protection] (https://doi.org/10.1152/physrev.00004.2008). Wallace, J. L. (2008). Physiological Reviews.
- [The inflammatory reflex] (https://doi.org/10.1038/416853a). Tracey, K. J. (2002). Nature.
- [Vagus nerve as modulator of the brain–gut axis in psychiatric and inflammatory disorders] (https://doi.org/10.3389/fpsyt.2018.00044). Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018). Frontiers in Psychiatry.
- [Wheat amylase trypsin inhibitors drive intestinal inflammation via TLR4] (https://doi.org/10.1084/jem.20102660). Junker, Y., Zeissig, S., et al. (2012). Journal of Experimental Medicine.
- [Zonulin, regulation of tight junctions, and autoimmune diseases] (https://doi.org/10.1111/j.1749-6632.2012.06538.x). Fasano, A. (2012). Annals of the New York Academy of Sciences.
- [European Society Pediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020] (https://doi.org/10.1097/MPG.0000000000002497). Husby, S., Koletzko, S., et al. (2020). Journal of Pediatric Gastroenterology and Nutrition.
- [Gluten sensitivity: From gut to brain] (https://doi.org/10.1016/S1474-4422(09)70290-X). Hadjivassiliou, M., et al. (2010). The Lancet Neurology.
- [Bone mineral density in coeliac disease] (https://doi.org/10.3109/00365529609031848). Valdimarsson, T., et al. (1996). Scandinavian Journal of Gastroenterology.
- [Risk of ischemic heart disease in patients with celiac disease: A population-based study] (https://doi.org/10.1111/j.1365-2796.2011.02455.x). Emilsson, L., et al. (2011). Journal of Internal Medicine.
- [Celiac disease and non-celiac gluten sensitivity] (https://doi.org/10.1136/bmj.i5257). Leonard, M. M., & Sapone, A. (2016). BMJ.
- [Emerging therapies for celiac disease] (https://doi.org/10.1053/j.gastro.2015.04.006). Kelly, C. P., Bai, J. C., Liu, E., & Leffler, D. A. (2015). Gastroenterology.
- [Immunopathogenesis of dermatitis herpetiformis] (https://doi.org/10.1111/bjd.12808). Salmi, T. T., et al. (2014). British Journal of Dermatology.
- [Zonulin, barrier functions, and chronic inflammatory diseases] (https://doi.org/10.1080/21688370.2016.1251386). Sturgeon, C., & Fasano, A. (2016). Tissue Barriers.
- [A model of neurovisceral integration] (https://doi.org/10.1016/S0301-0511(99)00047-2). Thayer, J. F., & Lane, R. D. (2000). Biological Psychology.
- [Why sleep is important for health: A psychoneuroimmunology perspective] (https://doi.org/10.1146/annurev-psych-010213-115205). Irwin, M. R. (2015). Annual Review of Psychology.
- [Central hyperexcitability and musculoskeletal pain] (https://doi.org/10.1016/j.math.2011.06.003). Sterling, M., et al. (2011). Manual Therapy.
- [Review article: Lactose intolerance in clinical practice—Myths and realities] (https://doi.org/10.1111/j.1365-2036.2008.03723.x). Lomer, M. C. E., Parkes, G. C., & Sanderson, J. D. (2008). Alimentary Pharmacology & Therapeutics.
SEO tags: celiac disease, non-celiac gluten sensitivity, NCGS, gliadin, zonulin, tissue transglutaminase, tTG IgA, gluten challenge, integrative chiropractic, functional medicine, gut permeability, leaky gut, dermatitis herpetiformis, vagus nerve, HRV, autonomic balance, rehabilitation, personal injury, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, El Paso Texas, evidence-based care, gluten-free diet, amylase-trypsin inhibitors, fructans, microbiome, osteopenia, neuropathy, cardiovascular Risk.
Post Disclaimer *
General Disclaimer *
Professional Scope of Practice *
The information herein on "The Immune System and Gluten Sensitivity from Celiac Disease" is not intended to replace a one-on-one relationship with a qualified health care professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional.
Blog Information & Scope Discussions
Welcome to El Paso's Premier Fitness, Injury Care Clinic & Wellness Blog, where Dr. Alex Jimenez, DC, FNP-C, a Multi-State board-certified Family Practice Nurse Practitioner (FNP-BC) and Chiropractor (DC), presents insights on how our multidisciplinary team is dedicated to holistic healing and personalized care. Our practice aligns with evidence-based treatment protocols inspired by integrative medicine principles, similar to those found on this site and our family practice-based chiromed.com site, focusing on restoring health naturally for patients of all ages.
Our areas of multidisciplinary practice include Wellness & Nutrition, Chronic Pain, Personal Injury, Auto Accident Care, Work Injuries, Back Injury, Low Back Pain, Neck Pain, Migraine Headaches, Sports Injuries, Severe Sciatica, Scoliosis, Complex Herniated Discs, Fibromyalgia, Chronic Pain, Complex Injuries, Stress Management, Functional Medicine Treatments, and in-scope care protocols.
Our information scope is multidisciplinary, focusing on musculoskeletal and physical medicine, wellness, contributing etiological viscerosomatic disturbances within clinical presentations, associated somato-visceral reflex clinical dynamics, subluxation complexes, sensitive health issues, and functional medicine articles, topics, and discussions.
We provide and present clinical collaboration with specialists from various disciplines. Each specialist is governed by their professional scope of practice and their jurisdiction of licensure. We use functional health & wellness protocols to treat and support care for musculoskeletal injuries or disorders.
Our videos, posts, topics, and insights address clinical matters and issues that are directly or indirectly related to our clinical scope of practice.
Our office has made a reasonable effort to provide supportive citations and has identified relevant research studies that support our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We understand that we cover matters that require an additional explanation of how they may assist in a particular care plan or treatment protocol; therefore, to discuss the subject matter above further, please feel free to ask Dr. Alex Jimenez, DC, APRN, FNP-BC, or contact us at 915-850-0900.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multistate Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
Verify Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
(Board Certified: Family Practice Nurse Practitioner—Multistate)*
(Licensed Nurse Practitioner & Chiropractor - Multistate)*
Clinical Director
Digital Business Card
Dr. Maria Cardenas, MD
(Board Certified: Internal Medicine)
(Licensed Medical Doctor)
Medical Director, Clinical Director & Collaborative Physician
NPI # 1164426748
MD License #: J2933
Licenses and Board Certifications:
MD: Medical Doctor
DC: Doctor of Chiropractic
APRNP: Advanced Practice Registered Nurse
FNP-BC: Family Practice Specialization (Multi-State Board Certified)
RN: Registered Nurse (Multi-State Compact License)
CFMP: Certified Functional Medicine Provider
MSN-FNP: Master of Science in Family Practice Medicine
MSACP: Master of Science in Advanced Clinical Practice
IFMCP: Institute of Functional Medicine
CCST: Certified Chiropractic Spinal Trauma
ATN: Advanced Translational Neutrogenomics
Memberships & Associations:
TCA: Texas Chiropractic Association: Member ID: 104311
AANP: American Association of Nurse Practitioners: Member ID: 2198960
ANA: American Nurse Association: Member ID: 06458222 (District TX01)
TNA: Texas Nurse Association: Member ID: 06458222
NPI: 1205907805
National Provider Identifier
| Primary Taxonomy |
Selected Taxonomy |
State |
License Number |
| No |
111N00000X - Chiropractor |
NM |
DC2182 |
| Yes |
111N00000X - Chiropractor |
TX |
DC5807 |
| Yes |
363LF0000X - Nurse Practitioner - Family |
TX |
1191402 |
| Yes |
363LF0000X - Nurse Practitioner - Family |
FL |
11043890 |
| Yes |
363LF0000X - Nurse Practitioner - Family |
CO |
C-APN.0105610-C-NP |
| Yes |
363LF0000X - Nurse Practitioner - Family |
NY |
N25929 |
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
(Board Certified: Family Practice Nurse Practitioner—Multistate)*
(Licensed Nurse Practitioner & Chiropractor - Multistate)*
Clinical Director
Digital Business Card
Dr. Maria Cardenas, MD
(Board Certified: Internal Medicine)*
(Licensed Medical Doctor)*
Medical Director, Clinical Director & Collaborative Physician
NPI # 1164426748
MD License #: J2933